HOME
Donate now
EN FR
Current language is English. Click to change language
EN FR

Evidence Synthesis and Classification Branch (ESC)

Publications

All recent publications: 2025-2021

View Key Publications

 

  1. Cogliano VJ, Corsini E, Fournier A, Nelson HH, Sergi CM, Antunes AMM, et al. (2025). Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus. Lancet Oncol. 26(1): 15-16. https://doi.org/10.1016/S1470-2045(24)00685-5 PMID: 39622256
  2. Centeno BA, Saieg M, Siddiqui MT, Perez-Machado M, Layfield LJ, Weynand B, et al. (2024). The World Health Organization Reporting System for Pancreaticobiliary Cytopathology: Overview and Summary. Cancer Cytopathol. 132(7): 396-418. https://doi.org/10.1002/cncy.22806 PMID: 38709670
  3. Colling R, Indave I, Del Aguila J, Jimenez RC, Campbell F, Chechlinska M, et al. (2024). A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor Pathology. Mod Pathol. 37(1): 100357. https://doi.org/10.1016/j.modpat.2023.100357 PMID: 37866639
  4. Colling R, Indave I, Del Aguilla J, Cierco Jimenez R, Campbell F, Chechlinska M, et al. (2024). Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group. Mod Pathol. 37(7): 100515. https://doi.org/10.1016/j.modpat.2024.100515 PMID: 38763419
  5. Daniels RD, Bertke SJ, Kelly-Reif K, Richardson DB, Haylock R, Laurier D, et al. (2024). Updated findings on temporal variation in radiation-effects on cancer mortality in an international cohort of nuclear workers (INWORKS). Eur J Epidemiol. 39(11): 1277-1286. https://doi.org/10.1007/s10654-024-01178-6 PMID: 39576361
  6. Giesen C, Del Aguila Mejia J, Armon S, Cierco Jimenez R, Myles N, Goldman-Levy G, et al. (2024). Exploratory evidence maps for the WHO Classification of Tumours 5th edition for lung and thymus tumors. Virchows Arch. 485(5): 869-878. https://doi.org/10.1007/s00428-024-03886-6 PMID: 39448408
  7. Harewood R, Rothwell JA, Besevic J, Viallon V, Achaintre D, Gicquiau A, et al. (2024). Association between pre-diagnostic circulating lipid metabolites and colorectal cancer risk: a nested case-control study in the European Prospective Investigation into Cancer and Nutrition (EPIC). EBioMedicine. 101: 105024. https://doi.org/10.1016/j.ebiom.2024.105024 PMID: 38412638
  8. Kreuzer M, Sommer M, Deffner V, Bertke S, Demers PA, Kelly-Reif K, et al. (2024). Lifetime excess absolute risk for lung cancer due to exposure to radon: results of the pooled uranium miners cohort study PUMA. Radiat Environ Biophys. 63(1): 7-16. https://doi.org/10.1007/s00411-023-01049-w PMID: 38172372
  9. Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, et al. (2024). Leukaemia, lymphoma, and multiple myeloma mortality after low-level exposure to ionising radiation in nuclear workers (INWORKS): updated findings from an international cohort study. Lancet Haematol. 11(10): e761-e769. https://doi.org/10.1016/S2352-3026(24)00240-0 PMID: 39222647
  10. Middleton DRS, Wedekind R, Hall AL, Suonio E, DeBono N, Vermeulen R, et al. (2024). Critical reviews of exposure assessment in carcinogenic hazard identification: the IARC Monographs experience. Occup Environ Med. 81(7): 366-372. https://doi.org/10.1136/oemed-2023-109277 PMID: 39033030
  11. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. (2024). The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 4(3): 100500. https://doi.org/10.1016/j.xgen.2024.100500 PMID: 38325367
  12. Richardson DB, Laurier D, Leuraud K, Gillies M, Haylock R, Kelly-Reif K, et al. (2024). Site-specific cancer mortality after low level exposure to ionizing radiation: Findings from an update of the International Nuclear Workers Study (INWORKS). Am J Epidemiol. https://doi.org/10.1093/aje/kwae256 PMID: 39108174
  13. Rumgay H, Nethan ST, Shah R, Vignat J, Ayo-Yusuf O, Chaturvedi P, et al. (2024). Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis. Lancet Oncol. 25(11): 1413-1423. https://doi.org/10.1016/S1470-2045(24)00458-3 PMID: 39393386
  14. Senkin S, Moody S, Diaz-Gay M, Abedi-Ardekani B, Cattiaux T, Ferreiro-Iglesias A, et al. (2024). Geographic variation of mutagenic exposures in kidney cancer genomes. Nature. 629(8013): 910-918. https://doi.org/10.1038/s41586-024-07368-2 PMID: 38693263
  15. Shafique A, Gonzalez R, Pantanowitz L, Tan PH, Machado A, Cree IA, et al. (2024). A Preliminary Investigation into Search and Matching for Tumor Discrimination in World Health Organization Breast Taxonomy Using Deep Networks. Mod Pathol. 37(2): 100381. https://doi.org/10.1016/j.modpat.2023.100381 PMID: 37939901
  16. Sohi I, Rehm J, Saab M, Virmani L, Franklin A, Sanchez G, et al. (2024). Alcoholic beverage consumption and female breast cancer risk: A systematic review and meta-analysis of prospective cohort studies. Alcohol Clin Exp Res (Hoboken). 48(12): 2222-2241. https://doi.org/10.1111/acer.15493 PMID: 39581746
  17. Stayner LT, Carreon-Valencia T, Demers PA, Fritz JM, Sim MR, Stewart P, et al. (2024). Carcinogenicity of talc and acrylonitrile. Lancet Oncol. 25(8): 962-963. https://doi.org/10.1016/S1470-2045(24)00384-X PMID: 38976996
  18. Terry MB, English DR, Freudenheim JL, Lauby-Secretan B, Gapstur SM (2024). Alcohol cessation and breast cancer risk stratified by hormone receptor status. Breast Cancer Res. 26(1): 179. https://doi.org/10.1186/s13058-024-01937-z PMID: 39639353
  19. Tran TV, Schonfeld SJ, Pasqual E, Haymart MR, Morton LM, Kitahara CM (2024). All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States. Thyroid. 34(2): 215-224. https://doi.org/10.1089/thy.2023.0449 PMID: 38149602
  20. Turner MC, Straif K, Kogevinas M, Schubauer-Berigan MK (2024). Five decades of occupational cancer epidemiology. Scand J Work Environ Health. 50(7): 489-502. https://doi.org/10.5271/sjweh.4190 PMID: 39311490
  21. Wong CJW, Md Nasir ND, Koh VCY, Campbell F, Fox S, Lakhani SR, et al. (2024). Mapping the cited evidence of ductal carcinoma in situ from the 5th edition of the World Health Organisation classification of tumours of the breast. Histopathology. 85(3): 510-520. https://doi.org/10.1111/his.15279 PMID: 39030792
  22. Zahm S, Bonde JP, Chiu WA, Hoppin J, Kanno J, Abdallah M, et al. (2024). Carcinogenicity of perfluorooctanoic acid and perfluorooctanesulfonic acid. Lancet Oncol. 25(1): 16-17. https://doi.org/10.1016/S1470-2045(23)00622-8 PMID: 38043561
  23. Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, et al. (2023). Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720-1748. Leukemia. 37(9): 1944-1951. https://doi.org/10.1038/s41375-023-01962-5 PMID: 37468552
  24. Bresalier RS, Senore C, Young GP, Allison J, Benamouzig R, Benton S, et al. (2023). An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles. Gut. 72(10): 1904-1918. https://doi.org/10.1136/gutjnl-2023-329701 PMID: 37463757
  25. Canberk S, Field A, Bubendorf L, Chandra A, Cree IA, Engels M, et al. (2023). A brief review of the WHO reporting system for lung cytopathology. Journal of the American Society of Cytopathology. 12(4): 251-257. https://doi.org/10.1016/j.jasc.2023.04.002 PMID: 37156705
  26. Cattley RC, Kromhout H, Sun M, Tokar EJ, Abdallah MA, Bauer AK, et al. (2023). Carcinogenicity of anthracene, 2-bromopropane, butyl methacrylate, and dimethyl hydrogen phosphite. Lancet Oncol. 24(5): 431-432. https://doi.org/10.1016/S1470-2045(23)00141-9 PMID: 36966774
  27. Cree IA (2023). Editorial: The new WHO cytopathology reporting systems-extending the WHO classification of tumors. J Am Soc Cytopathol. 12(4): 239-242. https://doi.org/10.1016/j.jasc.2023.04.004 PMID: 37244847
  28. Cree IA, Khoury JD (2023). WHO or International Consensus Classification: Is the Difference Worth It? J Clin Oncol. 41(31): 4937-4938. https://doi.org/10.1200/jco.23.01172 PMID: 37467455
  29. DeBono NL, Daniels RD, Beane Freeman LE, Graber JM, Hansen J, Teras LR, et al. (2023). Firefighting and Cancer: A Meta-analysis of Cohort Studies in the Context of Cancer Hazard Identification. Saf Health Work. 14(2): 141-152. https://doi.org/10.1016/j.shaw.2023.02.003 PMID: 37389311
  30. Gapstur SM, Bouvard V, Nethan ST, Freudenheim JL, Abnet CC, English DR, et al. (2023). The IARC Perspective on Alcohol Reduction or Cessation and Cancer Risk. N Engl J Med. 389(26): 2486-2494. https://doi.org/10.1056/NEJMsr2306723 PMID: 38157507
  31. Gregorio C, Thakur S, Camara Rivero R, Marcia Dos Santos Machado S, Cuenin C, Carreira C, et al. (2023). Telomere length assessment and molecular characterization of TERT gene promoter in periampullary carcinomas. Gene. 873: 147460. https://doi.org/10.1016/j.gene.2023.147460 PMID: 37150235
  32. Haycock PC, Borges MC, Burrows K, Lemaitre RN, Burgess S, Khankari NK, et al. (2023). The association between genetically elevated polyunsaturated fatty acids and risk of cancer. EBioMedicine. 91: 104510. https://doi.org/10.1016/j.ebiom.2023.104510 PMID: 37086649
  33. Kelly-Reif K, Bertke S, Daniels RD, Richardson DB, Schubauer-Berigan MKD (2023). Authors’ response: Solid cancer mortality among US radiation workers. Int J Epidemiol. 52(6): 1994-1995. https://doi.org/10.1093/ije/dyad132 PMID: 37741933
  34. Kelly-Reif K, Bertke SJ, Daniels RD, Richardson DB, Schubauer-Berigan MK (2023). Ionizing radiation and solid cancer mortality among US nuclear facility workers. Int J Epidemiol. 52(4): 1015-1024. https://doi.org/10.1093/ije/dyad075 PMID: 37253388
  35. Kelly-Reif K, Bertke SJ, Rage E, Demers PA, Fenske N, Deffner V, et al. (2023). Radon and lung cancer in the pooled uranium miners analysis (PUMA): highly exposed early miners and all miners. Occup Environ Med. 80(7): 385-391. https://doi.org/10.1136/oemed-2022-108532 PMID: 37164624
  36. Lennerz JK, Salgado R, Kim GE, Sirintrapun SJ, Thierauf JC, Singh A, et al. (2023). Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML. Clin Chem Lab Med. 61(4): 544-557. https://doi.org/10.1515/cclm-2022-1151 PMID: 36696602
  37. M Filho A, Turner MC, Warnakulasuriya S, Richardson DB, Hosseini B, Kamangar F, et al. (2023). The carcinogenicity of opium consumption: a systematic review and meta-analysis. Eur J Epidemiol. 38(4): 373-389. https://doi.org/10.1007/s10654-023-00969-7 PMID: 36773182
  38. Malir F, Pickova D, Toman J, Grosse Y, Ostry VM (2023). Hazard characterisation for significant mycotoxins in food. Mycotoxin Res. 39(2): 81-93. https://doi.org/10.1007/s12550-023-00478-2 PMID: 36930431
  39. Mandrik O, Roitberg F, Lauby-Secretan B, Parak U, Ramadas K, Varenne B, et al. (2023). Perspective on oral cancer screening: Time for implementation research and beyond. J Cancer Policy. 35: 100381. https://doi.org/10.1016/j.jcpo.2022.100381 PMID: 36599217
  40. Md Nasir ND, Koh VCY, Cree IA, Ruiz BII, Del Aguila J, Armon S, et al. (2023). Phyllodes tumour evidence gaps mapped from the 5th edition of the WHO classification of tumours of the breast. Histopathology. 82(5): 704-712. https://doi.org/10.1111/his.14856 PMID: 36579383
  41. Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, et al. (2023). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. https://doi.org/10.1111/his.14824 PMID: 36221864
  42. Milman T, Grossniklaus HE, Goldman-Levy G, Kivela TT, Coupland SE, White VA, et al. (2023). The 5th Edition of the World Health Organization Classification of Tumours of the Eye and Orbit. Ocul Oncol Pathol. 9(3-4): 71-95. https://doi.org/10.1159/000530730 PMID: 37900189
  43. Netto GJ, Amin MB, Comperat EM, Gill AJ, Hartmann A, Moch H, et al. (2023). Prostate Adenocarcinoma Grade Group 1: Rationale for Retaining a Cancer Label in the 2022 World Health Organization Classification. Eur Urol. 83(4): 301-303. https://doi.org/10.1016/j.eururo.2022.09.015 PMID: 36202687
  44. Pedroso CM, Normando AGC, Siracusa CS, Lauby-Secretan B, Nethan ST, Tomasi RA, et al. (2023). Pan-American prevalence of smokeless tobacco use and association with oral potentially malignant disorders and head and neck cancer: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 136(3): 322-332. https://doi.org/10.1016/j.oooo.2023.02.019 PMID: 37076380
  45. Pega F, Momen NC, Streicher KN, Leon-Roux M, Neupane S, Schubauer-Berigan MK, et al. (2023). Global, regional and national burdens of non-melanoma skin cancer attributable to occupational exposure to solar ultraviolet radiation for 183 countries, 2000–2019: A systematic analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury. Environ Int. 181: 108226. https://doi.org/10.1016/j.envint.2023.108226 PMID: 37945424
  46. Pitman MB, Centeno BA, Reid MD, Saeig M, Siddiqui MT, Layfield LJ, et al. (2023). A brief review of the WHO reporting system for pancreaticobiliary cytopathology. J Am Soc Cytopathol. 12(4): 243-250. https://doi.org/10.1016/j.jasc.2023.03.002 PMID: 37003924
  47. Pitman MB, Centeno BA, Reid MD, Siddiqui MT, Layfield LJ, Perez-Machado M, et al. (2023). The World Health Organization Reporting System for Pancreaticobiliary Cytopathology. Acta Cytol. 67(3): 304-320. https://doi.org/10.1159/000527912 PMID: 36516741
  48. Riboli E, Beland FA, Lachenmeier DW, Marques MM, Phillips DH, Schernhammer E, et al. (2023). Carcinogenicity of aspartame, methyleugenol, and isoeugenol. Lancet Oncol. 24(8): 848-850. https://doi.org/10.1016/S1470-2045(23)00341-8 PMID: 37454664
  49. Richardson DB, Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, et al. (2023). Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ. 382: e074520. https://doi.org/10.1136/bmj-2022-074520 PMID: 37586731
  50. Rubin MA, Amin MB, Comperat E, Gill A, Hartman A, Menon S, et al. (2023). Reply to Yongbao Wei, Haijian Huang, and Liefu Ye’s Letter to the Editor re: George J. Netto, Mahul B. Amin, Daniel M. Berney, et al. The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 2022;82:469-82. Eur Urol. 83(1): e16-e17. https://doi.org/10.1016/j.eururo.2022.09.021 PMID: 36202688
  51. Schmitt FC, Bubendorf L, Canberk S, Chandra A, Cree IA, Engels M, et al. (2023). The World Health Organization Reporting System for Lung Cytopathology. Acta Cytol. 67(1): 80-91. https://doi.org/10.1159/000527580 PMID: 36509066
  52. Schorb S, Gleiss K, Wedekind R, Suonio E, Kull AK, Kuntz M, et al. (2023). Assessment of Aspartame (E951) Occurrence in Selected Foods and Beverages on the German Market 2000-2022. Foods. 12(11). https://doi.org/10.3390/foods12112156 PMID: 37297402
  53. Schubauer-Berigan MK (2023). Invited Perspective: Good Measure-Assessing the Impact of Cancer Hazard Identification on Policies for Cancer Prevention. Environ Health Perspect. 131(12): 121302. https://doi.org/10.1289/EHP14099 PMID: 38088578
  54. Schubauer-Berigan MK, Richardson DB, Fox MP, Fritschi L, Guseva Canu I, Pearce N, et al. (2023). IARC-NCI workshop on an epidemiological toolkit to assess biases in human cancer studies for hazard identification: beyond the algorithm. Occup Environ Med. 80(3): 119-120. https://doi.org/10.1136/oemed-2022-108724 PMID: 36717257
  55. Siebert R, Schuh A, Ott G, Cree IA, Du MQ, Ferry J, et al. (2023). Response to the Comments from the Groupe Francophone de Cytogenetique Hematologique (GFCH) on the 5th edition of the World Health Organization classification of haematolymphoid tumors. Leukemia. 37(5): 1170-1172. https://doi.org/10.1038/s41375-023-01872-6 PMID: 36973349
  56. Simms KT, Keane A, Nguyen DTN, Caruana M, Hall MT, Lui G, et al. (2023). Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat Med. 29(12): 3050-3058. https://doi.org/10.1038/s41591-023-02600-4 PMID: 38087115
  57. Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. (2023). Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative. Lancet Glob Health. 11(2): e197-e206. https://doi.org/10.1016/S2214-109X(22)00501-0 PMID: 36528031
  58. Turner MC, Cogliano V, Guyton K, Madia F, Straif K, Ward EM, et al. (2023). Research Recommendations for Selected IARC-Classified Agents: Impact and Lessons Learned. Environ Health Perspect. 131(10): 105001. https://doi.org/10.1289/ehp12547 PMID: 37902675
  59. Van Puyvelde H, Dimou N, Katsikari A, Indave Ruiz BI, Godderis L, Huybrechts I, et al. (2023). The association between dietary intakes of methionine, choline and betaine and breast cancer risk: A systematic review and meta-analysis. Cancer Epidemiol. 83: 102322. https://doi.org/10.1016/j.canep.2023.102322 PMID: 36701983
  60. Zablotska LB, Richardson DB, Golden A, Pasqual E, Smith B, Rage E, et al. (2023). The epidemiology of lung cancer following radiation exposure. Int J Radiat Biol. 99(3): 569-580. https://doi.org/10.1080/09553002.2022.2110321 PMID: 35947399
  61. Baan RA, Straif K (2022). The Monographs Programme of the International Agency for Research on Cancer. A brief history of its Preamble. ALTEX. 39(3): 443-450. https://doi.org/10.14573/altex.2004081 PMID: 34164695
  62. Beard JD, Verdeja MA, Bonsrah DA, Westfall SD, Steege AL, Schubauer-Berigan MK (2022). Crosswalks to Convert US Census Bureau Industry and Occupation Codes, 1980-2018. Epidemiology. 33(2): e8-e9. https://doi.org/10.1097/EDE.0000000000001440 PMID: 34799471
  63. Berney DM, Cree I, Rao V, Moch H, Srigley JR, Tsuzuki T, et al. (2022). An introduction to the WHO 5th edition 2022 classification of testicular tumours. Histopathology. 81(4): 459-466. https://doi.org/10.1111/his.14675 PMID: 35502823
  64. Bouvard V, Nethan ST, Singh D, Warnakulasuriya S, Mehrotra R, Chaturvedi AK, et al. (2022). IARC Perspective on Oral Cancer Prevention. N Engl J Med. 387(21): 1999-2005. https://doi.org/10.1056/NEJMsr2210097 PMID: 36378601
  65. Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. (2022). The IARC Perspective on Cervical Cancer Screening. Obstet Gynecol Surv. 77(3): 154-156. https://doi.org/10.1097/Ogx.0000000000001017
  66. Cierco Jimenez R, Lee T, Rosillo N, Cordova R, Cree IA, Gonzalez A, et al. (2022). Machine learning computational tools to assist the performance of systematic reviews: A mapping review. BMC Med Res Methodol. 22(1): 322. https://doi.org/10.1186/s12874-022-01805-4 PMID: 36522637
  67. Comperat E, Amin MB, Berney DM, Cree I, Menon S, Moch H, et al. (2022). What’s new in WHO fifth edition – urinary tract. Histopathology. 81(4): 439-446. https://doi.org/10.1111/his.14764 PMID: 35942645
  68. Cree IA (2022). From Counting Mitoses to Ki67 Assessment: Technical Pitfalls in the New WHO Classification of Endocrine and Neuroendocrine Tumors. Endocr Pathol. 33(1): 3-5. https://doi.org/10.1007/s12022-021-09701-1 PMID: 35028827
  69. Cree IA (2022). The WHO classification of haematolymphoid tumours: response to Swerdlow et al. Leukemia. 36(11): 2750. https://doi.org/10.1038/s41375-022-01694-y PMID: 36171281
  70. Cree IA (2022). The WHO Classification of Haematolymphoid Tumours. Leukemia. 36(7): 1701-1702. https://doi.org/10.1038/s41375-022-01625-x PMID: 35732830
  71. Cree IA, Lokuhetty D, Tan PH (2022). The World Health Organization Classification of Tumors and External Quality Assurance for Immunohistochemistry and Molecular Pathology. Arch Pathol Lab Med. 146(11): 1303-1307. https://doi.org/10.5858/arpa.2021-0491-RA PMID: 35671156
  72. Del Aguila Mejia J, Armon S, Campbell F, Colling R, Chechlinska M, Kowalewska M, et al. (2022). Understanding the use of evidence in the WHO Classification of Tumours: a protocol for an evidence gap map of the classification of tumours of the lung. BMJ Open. 12(10): e061240. https://doi.org/10.1136/bmjopen-2022-061240 PMID: 36220326
  73. Demers PA, DeMarini DM, Fent KW, Glass DC, Hansen J, Adetona O, et al. (2022). Carcinogenicity of occupational exposure as a firefighter. Lancet Oncol. 23(8): 985-986. https://doi.org/10.1016/S1470-2045(22)00390-4 PMID: 35780778
  74. Goodman S, Chappell G, Guyton KZ, Pogribny IP, Rusyn I (2022). Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: An update of a systematic literature review. Mutat Res Rev Mutat Res. 789: 108408. https://doi.org/10.1016/j.mrrev.2021.108408 PMID: 35690411
  75. Guseva Canu I, Gaillen-Guedy A, Antilla A, Charles S, Fraize-Frontier S, Luce D, et al. (2022). Lung cancer mortality in the European cohort of titanium dioxide workers: a reanalysis of the exposure-response relationship. Occup Environ Med. 79(9): 637-640. https://doi.org/10.1136/oemed-2021-108030 PMID: 35501125
  76. Indave BI, Colling R, Campbell F, Tan PH, Cree IA (2022). Evidence-levels in pathology for informing the WHO classification of tumours. Histopathology. 81(4): 420-425. https://doi.org/10.1111/his.14648 PMID: 36089568
  77. Indave Ruiz BI, Armon S, Watanabe R, Uttley L, White VA, Lazar AJ, et al. (2022). Clonality, Mutation and Kaposi Sarcoma: A Systematic Review. Cancers (Basel). 14(5): 14. https://doi.org/10.3390/cancers14051201 PMID: 35267506
  78. Karagas MR, Wang A, Dorman DC, Hall AL, Pi J, Sergi CM, et al. (2022). Carcinogenicity of cobalt, antimony compounds, and weapons-grade tungsten alloy. Lancet Oncol. 23(5): 577-578. https://doi.org/10.1016/S1470-2045(22)00219-4 PMID: 35397803
  79. Kelly-Reif K, Bertke S, Daniels RD, Richardson DB, Schubauer-Berigan MK (2022). Nonmalignant respiratory disease mortality in male Colorado Plateau uranium miners, 1960-2016. Am J Ind Med. 65(10): 773-782. https://doi.org/10.1002/ajim.23419 PMID: 35941829
  80. Kelly-Reif K, Bertke SJ, Samet J, Sood A, Schubauer-Berigan MK (2022). Health burdens of uranium miners will extend beyond the radiation exposure compensation act deadline. Occup Environ Med. 79(7): 503-504. https://doi.org/10.1136/oemed-2022-108311 PMID: 35501126
  81. Kelly-Reif K, Sandler DP, Shore D, Schubauer-Berigan M, Troester M, Nylander-French L, et al. (2022). Lung and extrathoracic cancer incidence among underground uranium miners exposed to radon progeny in the Pribram region of the Czech Republic: a case-cohort study. Occup Environ Med. 79(2): 102-108. https://doi.org/10.1136/oemed-2021-107392 PMID: 34417337
  82. Kench JG, Amin MB, Berney DM, Comperat EM, Cree IA, Gill AJ, et al. (2022). WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer. Histopathology. 81(4): 447-458. https://doi.org/10.1111/his.14711 PMID: 35758185
  83. Lauby-Secretan B, Mackie A, Wentzensen N (2022). The IARC Perspective on Cervical Cancer Screening. Reply. N Engl J Med. 386(6): 607-608. https://doi.org/10.1056/NEJMc2119177 PMID: 35139285
  84. Lobo J, Ohashi R, Amin MB, Berney DM, Comperat EM, Cree IA, et al. (2022). WHO 2022 landscape of papillary and chromophobe renal cell carcinoma. Histopathology. 81(4): 426-438. https://doi.org/10.1111/his.14700 PMID: 35596618
  85. Luchini C, Pantanowitz L, Adsay V, Asa SL, Antonini P, Girolami I, et al. (2022). Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring. Mod Pathol. 35(6): 712-720. https://doi.org/10.1038/s41379-022-01055-1 PMID: 35249100
  86. Martins B, Normando AGC, Rodrigues-Fernandes CI, Wagner VP, Kowalski LP, Marques SS, et al. (2022). Global frequency and epidemiological profile of electronic cigarette users: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 548-561. https://doi.org/10.1016/j.oooo.2022.07.019 PMID: 36182650
  87. Menon S, Moch H, Berney DM, Cree IA, Srigley JR, Tsuzuki T, et al. (2022). WHO 2022 classification of penile and scrotal cancers: updates and evolution. Histopathology. 82(4): 508-520. https://doi.org/10.1111/his.14824 PMID: 36221864
  88. Michels N, Zouiouich S, Vanderbauwhede B, Vanacker J, Indave Ruiz BI, Huybrechts I (2022). Human microbiome and metabolic health: An overview of systematic reviews. Obes Rev. 23(4): e13409. https://doi.org/10.1111/obr.13409 PMID: 34978141
  89. Middleton DRS, Mmbaga BT, Menya D, Dzamalala C, Nyakunga-Maro G, Finch P, et al. (2022). Alcohol consumption and oesophageal squamous cell cancer risk in east Africa: findings from the large multicentre ESCCAPE case-control study in Kenya, Tanzania, and Malawi. Lancet Glob Health. 10(2): e236-e245. https://doi.org/10.1016/S2214-109X(21)00506-4 PMID: 34921758
  90. Moch H, Amin MB, Berney DM, Comperat EM, Gill AJ, Hartmann A, et al. (2022). The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol. 82(5): 458-468. https://doi.org/10.1016/j.eururo.2022.06.016 PMID: 35853783
  91. Netto GJ, Amin MB, Berney DM, Comperat EM, Gill AJ, Hartmann A, et al. (2022). The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs-Part B: Prostate and Urinary Tract Tumors. Eur Urol. 82(5): 469-482. https://doi.org/10.1016/j.eururo.2022.07.002 PMID: 35965208
  92. Paglioni MP, Khurram SA, Ruiz BII, Lauby-Secretan B, Normando AG, Ribeiro ACP, et al. (2022). Clinical predictors of malignant transformation and recurrence in oral potentially malignant disorders: A systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 134(5): 573-587. https://doi.org/10.1016/j.oooo.2022.07.006 PMID: 36153299
  93. Pfister SM, Reyes-Mugica M, Chan JKC, Hasle H, Lazar AJ, Rossi S, et al. (2022). A Summary of the Inaugural WHO Classification of Pediatric Tumors: Transitioning from the Optical into the Molecular Era. Cancer Discov. 12(2): 331-355. https://doi.org/10.1158/2159-8290.CD-21-1094 PMID: 34921008
  94. Pinello K, Baldassarre V, Steiger K, Paciello O, Pires I, Laufer-Amorim R, et al. (2022). Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2. Cancers (Basel). 14(6). https://doi.org/10.3390/cancers14061529 PMID: 35326681
  95. Reisfeld B, de Conti A, El Ghissassi F, Benbrahim-Tallaa L, Gwinn W, Grosse Y, et al. (2022). kc-hits: a tool to aid in the evaluation and classification of chemical carcinogens. Bioinformatics. 38(10): 2961-2962. https://doi.org/10.1093/bioinformatics/btac189 PMID: 35561175
  96. Richardson DB, Rage E, Demers PA, Do MT, Fenske N, Deffner V, et al. (2022). Lung Cancer and Radon: Pooled Analysis of Uranium Miners Hired in 1960 or Later. Environ Health Perspect. 130(5): 57010. https://doi.org/10.1289/EHP10669 PMID: 35604341
  97. Samet JM, Berrington de Gonzalez A, Lunn RM, Schubauer-Berigan MK (2022). Commentary: Role and communications of cancer hazard determinations. Carcinogenesis. 43(2): 79-81. https://doi.org/10.1093/carcin/bgac001 PMID: 35016221
  98. Thierauf JC, Farahani AA, Indave BI, Bard AZ, White VA, Smith CR, et al. (2022). Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma. Int J Mol Sci. 23(8): 4322. https://doi.org/10.3390/ijms23084322 PMID: 35457138
  99. White VA, Hyrcza MD, Lennerz JK, Thierauf J, Lokuhetty D, Cree IA, et al. (2022). Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities? Mod Pathol. 35(10): 1484-1493. https://doi.org/10.1038/s41379-022-01100-z PMID: 35871081
  100. Yadav K, Cree I, Field A, Vielh P, Mehrotra R (2022). Importance of Cytopathologic Diagnosis in Early Cancer Diagnosis in Resource-Constrained Countries. JCO Glob Oncol. 8: e2100337. https://doi.org/10.1200/GO.21.00337 PMID: 35213215
  101. Arroyave WD, Mehta SS, Guha N, Schwingl P, Taylor KW, Glenn B, et al. (2021). Challenges and recommendations on the conduct of systematic reviews of observational epidemiologic studies in environmental and occupational health. J Expo Sci Environ Epidemiol. 31(1): 21-30. https://doi.org/10.1038/s41370-020-0228-0 PMID: 32415298
  102. Barupal DK, Schubauer-Berigan MK, Korenjak M, Zavadil J, Guyton KZ (2021). Prioritizing cancer hazard assessments for IARC Monographs using an integrated approach of database fusion and text mining. Environ Int. 156: 106624. https://doi.org/10.1016/j.envint.2021.106624 PMID: 33984576
  103. Bilal M, Raza SEA, Azam A, Graham S, Ilyas M, Cree IA, et al. (2021). Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study. Lancet Digit Health. 3(12): e763-e772. https://doi.org/10.1016/S2589-7500(21)00180-1 PMID: 34686474
  104. Bouvard V, Wentzensen N, Mackie A, Berkhof J, Brotherton J, Giorgi-Rossi P, et al. (2021). The IARC Perspective on Cervical Cancer Screening. N Engl J Med. 385(20): 1908-1918. https://doi.org/10.1056/NEJMsr2030640 PMID: 34758259
  105. Bruford EA, Antonescu CR, Carroll AJ, Chinnaiyan A, Cree IA, Cross NCP, et al. (2021). HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia. 35(11): 3040-3043. https://doi.org/10.1038/s41375-021-01436-6 PMID: 34615987
  106. Chow ZL, Indave BI, Lokuhetty MDS, Ochiai A, Cree IA, White VA (2021). Misleading terminology in pathology: lack of definitions hampers communication. Virchows Arch. 479(2): 425-430. https://doi.org/10.1007/s00428-021-03069-7 PMID: 33796909
  107. Chow ZL, Indave BI, Lokuhetty MDS, Ochiai A, Cree IA, White VA (2021). Correction to: Misleading terminology in pathology: Lack of definitions hampers communication. Virchows Arch. 479(2): 439. https://doi.org/10.1007/s00428-021-03101-w PMID: 33890126
  108. Cree IA, Indave Ruiz BI, Zavadil J, McKay J, Olivier M, Kozlakidis Z, et al. (2021). The International Collaboration for Cancer Classification and Research. Int J Cancer. 148(3): 560-571. https://doi.org/10.1002/ijc.33260 PMID: 32818326
  109. Cree IA, Tan PH, Travis WD, Wesseling P, Yagi Y, White VA, et al. (2021). Counting mitoses: SI(ze) matters! Mod Pathol. 34(9): 1651-1657. https://doi.org/10.1038/s41379-021-00825-7 PMID: 34079071
  110. Fraser K, Hubbs A, Yanamala N, Mercer RR, Stueckle TA, Jensen J, et al. (2021). Histopathology of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities in a murine model. Part Fibre Toxicol. 18(1): 47. https://doi.org/10.1186/s12989-021-00440-z PMID: 34923995
  111. group IMV (2021). Carcinogenicity of gentian violet, leucogentian violet, malachite green, leucomalachite green, and CI Direct Blue 218. Lancet Oncol. 22(5): 585-586. https://doi.org/10.1016/S1470-2045(21)00178-9 PMID: 33773614
  112. Guyton KZ, Schubauer-Berigan MK (2021). Invited Perspective: Prioritizing Chemical Testing and Evaluation Using Validated in Vitro Assays Relevant to Key Characteristics. Environ Health Perspect. 129(7): 71303. https://doi.org/10.1289/EHP9507 PMID: 34287027
  113. Jimenez RC, Casajuana-Martin N, Garcia-Recio A, Alcantara L, Pardo L, Campillo M, et al. (2021). The mutational landscape of human olfactory G protein-coupled receptors. BMC Biol. 19(1): 21. https://doi.org/10.1186/s12915-021-00962-0 PMID: 33546694
  114. Leske H, Dalgleish R, Lazar AJ, Reifenberger G, Cree IA (2021). A common classification framework for histone sequence alterations in tumours: an expert consensus proposal. J Pathol. 254(2): 109-120. https://doi.org/10.1002/path.5666 PMID: 33779999
  115. Leuraud K, Richardson DB, Cardis E, Daniels RD, Gillies M, Haylock R, et al. (2021). Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study. Radiat Environ Biophys. 60(1): 23-39. https://doi.org/10.1007/s00411-020-00890-7 PMID: 33479781
  116. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, et al. (2021). The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 23(8): 1231-1251. https://doi.org/10.1093/neuonc/noab106 PMID: 34185076
  117. Matos LL, Forster CHQ, Marta GN, Castro Junior G, Ridge JA, Hirata D, et al. (2021). The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model. Cancer Causes Control. 32(5): 459-471. https://doi.org/10.1007/s10552-021-01411-7 PMID: 33704627
  118. Michels N, De Backer F, Dimakopoulou M, Mane K, Indave I, Huybrechts I (2021). Eating disorders and the risk of developing cancer: a systematic review. Eat Weight Disord. 26(4): 1021-1035. https://doi.org/10.1007/s40519-020-01020-4 PMID: 33025526
  119. Mostovenko E, Dahm MM, Schubauer-Berigan MK, Eye T, Erdely A, Young TL, et al. (2021). Serum peptidome: diagnostic window into pathogenic processes following occupational exposure to carbon nanomaterials. Part Fibre Toxicol. 18(1): 39. https://doi.org/10.1186/s12989-021-00431-0 PMID: 34711247
  120. Reynolds RR, Davies MJ, Buffam FV, Dolman PJ, White VA (2021). Differences in 7th and 8th edition American Joint Committee on Cancer staging for periocular sebaceous carcinoma. Can J Ophthalmol. 56(1): 31-36. https://doi.org/10.1016/j.jcjo.2020.07.017 PMID: 32822657
  121. Richardson DB, Rage E, Demers PA, Do MT, DeBono N, Fenske N, et al. (2021). Mortality among uranium miners in North America and Europe: the Pooled Uranium Miners Analysis (PUMA). Int J Epidemiol. 50(2): 633-643. https://doi.org/10.1093/ije/dyaa195 PMID: 33232447
  122. Rusyn I, Arzuaga X, Cattley RC, Corton JC, Ferguson SS, Godoy P, et al. (2021). Key Characteristics of Human Hepatotoxicants as a Basis for Identification and Characterization of the Causes of Liver Toxicity. Hepatology. 74(6): 3486-3496. https://doi.org/10.1002/hep.31999 PMID: 34105804
  123. Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, et al. (2021). Diagnosis of digestive system tumours. Int J Cancer. 148(5): 1040-1050. https://doi.org/10.1002/ijc.33210 PMID: 32674220

 

 

 
View Key Publications

 

 

Evidence Synthesis and Classification
About Research Publications Related websites Personnel
Close Reading Mode
UP